Hexagon Capital Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-159
| Closed | -$29.4K | – | 1852 |
|
|
2024
Q4 | $29.4K | Buy |
+159
| New | +$29.4K | 0.01% | 651 |
|
|
2024
Q2 | – | Sell |
-4
| Closed | -$1.08K | – | 1473 |
|
|
2024
Q1 | $1.08K | Sell |
4
-8
| -67% | -$2.17K | ﹤0.01% | 1264 |
|
|
2023
Q4 | $2.84K | Hold |
12
| – | – | ﹤0.01% | 1072 |
|
|
2023
Q3 | $2.35K | Hold |
12
| – | – | ﹤0.01% | 1040 |
|
|
2023
Q2 | $2.52K | Hold |
12
| – | – | ﹤0.01% | 1035 |
|
|
2023
Q1 | $2.42K | Sell |
12
-19
| -61% | -$3.84K | ﹤0.01% | 1032 |
|
|
2022
Q4 | $6.76K | Hold |
31
| – | – | ﹤0.01% | 834 |
|
|
2022
Q3 | $6K | Buy |
31
+6
| +24% | +$1.16K | ﹤0.01% | 883 |
|
|
2022
Q2 | $5K | Hold |
25
| – | – | ﹤0.01% | 790 |
|
|
2022
Q1 | $7K | Hold |
25
| – | – | ﹤0.01% | 658 |
|
|
2021
Q4 | $9K | Hold |
25
| – | – | ﹤0.01% | 609 |
|
|
2021
Q3 | $10K | Hold |
25
| – | – | ﹤0.01% | 586 |
|
|
2021
Q2 | $9K | Sell |
25
-15
| -38% | -$5.4K | ﹤0.01% | 568 |
|
|
2021
Q1 | $11K | Sell |
40
-6
| -13% | -$1.65K | ﹤0.01% | 511 |
|
|
2020
Q4 | $11K | Hold |
46
| – | – | ﹤0.01% | 471 |
|
|
2020
Q3 | $10K | Buy |
+46
| New | +$10K | ﹤0.01% | 451 |
|